MedLife S.A.

Regulatory Filings • Dec 10, 2025

MedLife reaches a capitalization of EUR 1 billion on BVB and proves that it is the most valuable company in the healthcare sector in Romania

• After nine years of presence on BVB, MedLife reaffirms its role as a strategic player in the development of the Romanian capital market.
• Reaching this symbolic threshold confirms investors' confidence in a growth business model, based on acquisitions and built on continuous investments.
• In recent years, MedLife has accelerated investments in robotic technologies, drones for transporting biological samples or AI, and recently, the company has invested significantly in genomic research, becoming an important player in medical innovation at regional level.

Bucharest (December 10, 2025): MedLife, the largest private medical services network in Romania and the only company with Romanian capital among the top players in the industry, announces that it has reached a stock market capitalization of EUR 1 billion on the Bucharest Stock Exchange (BVB), thus becoming the most valuable company in the healthcare sector in Romania.

The moment represents a historic milestone for both the company and the local financial ecosystem, confirming the maturity of the capital market and the development potential of the private medical system. Reaching this symbolic threshold comes in a context marked by economic volatility and uncertainties, underlining the resilience of MedLife's business model and the strategic relevance of the medical sector. The evolution of the company's shares reflects investors' confidence in a strategy geared towards sustainable growth and operational performance.

Nine years after the listing on December 16, 2016, MedLife marks a path built on transparency, accountability and solid investments. During this period, the company has carried out one of the largest expansion programs in the Romanian private sector, consolidating over 60 acquisitions and developing a nationwide integrated medical platform.

In parallel, MedLife has consistently invested in technology, AI, robots, drones and medical teams, helping to increase access to modern healthcare services for millions of patients. At the same time, the company has played an essential role in the Romanian capital market ecosystem, setting new standards of transparency, reporting and corporate governance.

"Reaching the EUR 1 billion capitalization threshold is an important validation for us and proof that the MedLife model remains solid and relevant, regardless of the context. It is the result of consistent work over three decades and the trust that our investors, partners and colleagues have placed in us. We thank everyone for being part of this evolution.

We are going through a complex period, with economic, social and geopolitical pressures. However, we believe that, with the implementation of the latest public policies at national level, Romania has the chance to move in the right direction. As far as we are concerned, we remain focused on investments in innovation and medical research: genomics, artificial intelligence - especially in imaging and laboratory, the development of prevention programs and the continuation of personalized medicine projects.

***

We strongly believe that the training and quality of the MedLife medical staff have helped us to consolidate our position as a leader in Romanian private medicine, and by transforming it into a medical technology company we have become an important player in innovation not only in Romania, but also in the region.

On the other hand, it is not to be neglected that, amid a significant budget deficit and the inherent measures of the central government to reduce it in recent months, retail sales have fallen during this period according to INS figures, and will probably continue to decline at the end of this year. And, in the same context, the private medical sector has slightly slowed its growth. However, I have no doubt that, gradually, perhaps even starting with the second quarter of next year, we will have an important chance to resume sustainable growth," said Mihai Marcu, President and CEO of MedLife Group.

For MedLife, listing on the BVB has never been just about capital. It was about a paradigm shift. About the transition from an entrepreneurial business to a consolidated leader, capable of writing history in the field of medical services.

The company's evolution speaks for itself: from RON 466 million in total assets in 2016, the company reached over RON 3 billion in 2024. The expansion of the network nationwide, over 450 own medical units, together with over 60 M&A transactions, allowed the construction of the first integrated medical ecosystem in Romania, covering prevention, laboratory, outpatient, hospital, imaging and occupational medicine services.

Main financial achievements in the 9 years since the listing of BVB

• Total assets: from RON 466 million in 2016 to RON 3.02 billion in 2024, +548% compared to 2016
• Turnover: from RON 502 million in 2016 to RON 2.72 billion in 2024, +441% or 5.4 times compared to the time of listing
• EBITDA: from RON 70 million pro-forma in 2016 to RON 416 million pro-forma in 2024, +494% or 5.9 times compared to the time of listing
• Flagship performance: the first private operator in Romania to exceed the threshold of EUR 500 million pro-forma turnover

This evolution reflects not only the size and performance of the company, but also MedLife's impact on the entire private medical industry in Romania, through innovation and the development of a modern, integrated medical system oriented towards the real needs of patients.

***

About MedLife Group

MedLife started almost three decades ago, developed healthily and became the largest provider of private medical services in Romania. The Romanian entrepreneurs, who laid the foundations of this company, invested and got involved to bring change in the Romanian health system, believed in innovation and dared to aim as high as possible, in order to offer Romanian patients quality, professionalism, care and respect for their needs.

The company operates the most extensive network of clinics, one of the largest networks of medical laboratories, general and specialized hospitals and has the largest corporate customer base for Health Prevention Packages in the country. It is also, in terms of sales, one of the largest private healthcare players in Central and Eastern Europe.

MedLife Group has a track record of success in terms of both organic growth and growth through acquisitions. Its strong and experienced management team has been able to create and manage these growth opportunities, gaining valuable knowledge and experience that will allow it to find the best path for successful further expansion.

Being a Romanian company with tradition, MedLife has chosen to list on the Romanian Stock Exchange, being a model of listings on the local capital market. It has opened horizons, and through the corporate governance it has implemented, it has inspired other local companies to start on this path and help the development of Romanian capital and the economy. The shares issued by MedLife SA are admitted to trading on the regulated spot market administered by the Bucharest Stock Exchange, Premium Category, bearing the trading symbol "M".

During the pandemic, MedLife managed to play an essential role in society and gain a leading status in monitoring the pandemic through active involvement in the research area.

The company continues to invest in projects with an impact on the local community, in technology and infrastructure. It creates jobs and develops an ecosystem that contributes to the development and maintenance of a healthy Romania.